Adarza Timeline

/Adarza Timeline
24 01, 2017

St. Louis Business Journal: RiverVest leads $17M investment in Adarza, brings on new president

By |January 24th, 2017|Adarza News, Adarza Timeline, Blog|0 Comments

RiverVest leads $17 million investment in Adarza, brings on new president

19 01, 2017

ADARZA BIOSYSTEMS CLOSES ON $17 MILLION SERIES C FINANCING

By |January 19th, 2017|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY and ST LOUIS, MO (Jan. 19, 2017) – Adarza BioSystems, Inc., a leading next generation innovator in label-free, multiplex assays, announced today that it has closed a $17M Series C financing. Proceeds from the financing will be used to further expand production capacity in its St. Peters, MO manufacturing facility and fund final development [...]

24 03, 2016

Adarza BioSystems Completes $5 M Series-B Closing

By |March 24th, 2016|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, N.Y. ST LOUIS, MO – Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed a $5 M Series B financing. Proceeds from the financing will be used to expand production capacity in its St. Peters, MO manufacturing facility and launch its first immunoassay product consumable [...]

25 11, 2014

Horizon Discovery Group plc and Adarza BioSystems Enter Supply & Licensing Agreement

By |November 25th, 2014|Adarza News, Adarza Timeline, Press Releases|0 Comments

Agreement gives Horizon exclusive right to supply services on Ardaza’s multiplex label-free immunoassay technology.

24 10, 2014

Adarza BioSystems Selects Sunedison Semiconductor Site for Manufacturing Immunoassay Consumables

By |October 24th, 2014|Adarza News, Adarza Timeline|0 Comments

Adarza BioSystems, Inc. has executed an agreement with SunEdison Semiconductor to establish immunoassay consumable manufacturing facilities at its St. Peters, Missouri manufacturing site.

1 10, 2014

Adarza BioSystems Completes $6.8M Series-A Financing

By |October 1st, 2014|Adarza News, Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY:  Adarza BioSystems, Inc. a leading next generation innovator in label-free, multiplex assays announced today that it has closed the final tranche of its Series-A financing bringing the total Series-A financing amount to $6.8 million. Proceeds from the financing will be used to launch its first 100-plex immunoassay product consumable and instrument and accelerate [...]

17 04, 2013

BioGenerator Investment Helps Adarza BioSystems Establish Operations in St. Louis

By |April 17th, 2013|Adarza Timeline, Press Releases|0 Comments

Life Science company expands presence to St. Louis ST. LOUIS, MO:  BioGenerator recently led syndication of investment in Adarza BioSystems, Inc., to support further commercialization of the company’s immunoassay products. As part of the investment, Adarza will conduct its primary business and product development in St. Louis as well as its manufacturing activities. Adarza is [...]

4 02, 2013

Adarza BioSystems Awarded Federal Grant to Support Toxic Exposure Assessment Product Development

By |February 4th, 2013|Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY: Adarza BioSystems, Inc. has been awarded a $245,912 Small Business Innovation Research (SBIR) grant from the National Institute of Environmental Health Sciences (NIEHS) of the National Institutes of Health (NIH) to aid the company in its efforts to apply its breakthrough Arrayed Imaging Reflectometry (AIRTM) bioassay platform for the detection of environmental toxins in [...]

27 06, 2012

Missouri Technology Corporation Helps to Recruit Life Science Startup to Missouri with IDEA Funds Program

By |June 27th, 2012|Adarza News, Adarza Timeline|0 Comments

NEWS RELEASE FROM: Missouri Department of Economic Development Date: Thursday, June 27, 2012 JEFFERSON CITY, MO:  The Missouri Technology Corporation (MTC) today announced a significant investment in a life science startup company through its IDEA Funds program. MTC made a $200,000 investment in Adaraza BioSystems, Inc, a life science technology company that has developed a disruptive [...]

9 05, 2011

Adarza BioSystems Expands Its Board of Directors with Industry Leaders

By |May 9th, 2011|Adarza Timeline, Press Releases|0 Comments

ROCHESTER, NY: Adarza BioSystems, Inc. announced today that it has expanded its Board of Directors with the addition of two leading business executives: Dr. Heiner Dreismann, former CEO of Roche Molecular Systems and James Senall, President of High Tech Rochester. Dr. Dreismann brings a wealth of experience, contacts and insight to Adarza as it moves [...]